We first sought to determine whether there were differences in joint-derived CD8+ or CD4+ TRM cells between PsA (n = 8 samples from n = 7 different patients) versus RA (n = 5 samples from n = 5 patients) (see Table 1 for demographic and clinical information). The gene discussed is CD8A; the disease is rheumatoid arthritis.